Login
Navigate Fool.com
Will IMGN beat
the market?

ImmunoGen (NASDAQ: IMGN)

Community Rating: 4 Stars: Favorite

10.63 -0.26 (-2.39%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.82
Previous Close $10.89
Daily Range $10.44 - $10.90
52-Week Range $10.44 - $20.25
Market Cap $912.2M
P/E Ratio -13.78
Dividend (Yield) $0.00 (0.0%)
Volume 835,301
Average Daily Volume 950,211
Current FY EPS -$0.85

How do you think IMGN
will perform against the market?

Top IMGN Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted December 1, 2013

I ended my underperform on ImmunoGen a little prematurely in order to align my CAPS picks with the zzporte portfolio, so I missed my long-awaited catharsis of the sudden discontinuation of the NORTH t … More

0 Replies Reply Report this Post
 

NetscribeHealthC (< 20)
Submitted February 14, 2007

ImmunoGen develops therapeutics for the treatment of cancer. The company’s tumor-activated prodrug (TAP) technology uses antibodies to deliver a potent cytotoxic agent specifically to treat cancer cel … More

0 Replies Reply Report this Post

News & Commentary

3 Potentially Game-Changing Investigational Breast Cancer Drugs That May Soon Be Available

Find out which three breast cancer drug hopefuls may offer a vast improvement to patient quality of life.

Friday's ETF Movers: XBI, GDXJ

Why Geron, Restoration Hardware, and ImmunoGen Are Today's 3 Best Stocks

The S&P 500 suffers its worst loss in weeks following disappointing economic data, while Geron, Restoration Hardware, and ImmunoGen give investors a reason to smile.

Rising R&D Expenses Drive ImmunoGen's Q3 Loss Significantly Higher

Higher research and development costs coupled with an absence of milestone and license fee revenue sends ImmunoGen's loss markedly higher.

Sector Update: Healthcare Shares Flat to Lower Pre-Market; ImmunoGen's Q3 Net Loss Widens From Year

Sector Update: Healthcare Shares Flat to Lower Pre-Market; ImmunoGen's Q3 Net Loss Widens From Year Prior

Sector Update: Healthcares

The Fool Looks Ahead

Let's look at the stocks that will be making news in the week ahead.

Why Zogenix, ImmunoGen, and voxeljet Are Today's 3 Best Stocks

The Beige Book release and key economic data pumps up the S&P 500 while Zogenix, ImmunoGen, and voxeljet lead individual stocks to the upside.

Wednesday Sector Leaders: Biotechnology, Rubber & Plastics

Wednesday's ETF Movers: FBT, GDX

See More IMGN News...

Sector

Healthcare

Industry

Drugs

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks